NFG
RUBY

Next Financial Group’s Rubius Therapeutics, Inc RUBY Stock Holding History

Next Financial Group’s Portfolio RUBY Stock Details RUBY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2
Closed – – 2663
2020
Q4 		$0 Sell
2
-6,099
-100% -$36.2K ﹤0.01% 2444
2020
Q3 		$31K Buy
+6,101
New +$32.3K ﹤0.01% 1259
2020
Q2 		– Sell
-6,313
Closed -$28K – 2031
2020
Q1 		$28K Hold
6,313
– – ﹤0.01% 1165
2019
Q4 		$60K Buy
+6,313
New +$61.1K 0.01% 1122

Other funds holding RUBY

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AFM
Abbot Financial Management Andover, Massachusetts $239M AUM 27.19% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Next Financial Group's RUBY Position: Q1 2021 in Review

Next Financial Group sold out of Rubius Therapeutics, Inc (RUBY) in Q1 2021, closing a stake of 2 shares.

Next Financial Group first reported a position in RUBY in Q4 2019 and held it in 4 quarters. The position peaked at $60K in Q4 2019. 105 funds tracked by Wall St. Rank hold RUBY as of Q1 2021.

  • Next Financial Group reported no remaining Rubius Therapeutics, Inc position as of Q1 2021 after selling out during the quarter.
  • Next Financial Group sold 2 Rubius Therapeutics, Inc shares in Q1 2021.
  • Next Financial Group first reported a position in Rubius Therapeutics, Inc in Q4 2019 and held it in 4 quarters.
  • Next Financial Group's Rubius Therapeutics, Inc position peaked at $60K in Q4 2019.
  • 105 funds tracked by Wall St. Rank held Rubius Therapeutics, Inc as of Q1 2021.

Based on Next Financial Group's 13F filing for Q1 2021, filed 16 Apr 2021.